APA (7th ed.) Citation

Chen, E. Y., Kardosh, A., Nabavizadeh, N., Foster, B., Mayo, S. C., Billingsley, K. G., . . . Vaccaro, G. M. (2023). Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma. Cancer Medicine, 12(12), 12986. https://doi.org/10.1002/cam4.5971

Chicago Style (17th ed.) Citation

Chen, Emerson Y., et al. "Phase 2 Study of Preoperative Chemotherapy with Nab‐paclitaxel and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node‐positive Pancreatic Ductal Adenocarcinoma." Cancer Medicine 12, no. 12 (2023): 12986. https://doi.org/10.1002/cam4.5971.

MLA (9th ed.) Citation

Chen, Emerson Y., et al. "Phase 2 Study of Preoperative Chemotherapy with Nab‐paclitaxel and Gemcitabine Followed by Chemoradiation for Borderline Resectable or Node‐positive Pancreatic Ductal Adenocarcinoma." Cancer Medicine, vol. 12, no. 12, 2023, p. 12986, https://doi.org/10.1002/cam4.5971.